Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-26 @ 2:33 AM
Study NCT ID:
NCT00317902
Status:
COMPLETED
Last Update Posted:
2011-05-19
First Post:
2006-04-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)
Sponsor:
Ortho Biotech Products, L.P.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-21
First Submit QC Date:
None
Study First Post Date:
2006-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-05-17
Last Update Post Date:
2011-05-19
Last Update Post Date Type:
ESTIMATED